Abstract Recent evidence of inequalities in healthcare for sickle cell disease in the UK is lacking. We aimed to describe trends in hospital admissions for sickle cell anaemia (SCA), cystic fibrosis (CF) and haemophilia in England. We conducted a historical cohort study using Hospital Episode Statistics data of individuals with a primary diagnosis of SCA (n = 19,506), CF (n = 9,569) or haemophilia (n = 7,289) between 1st January 2013 and 31st December 2022.
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile
Articles by Daniel Dexter
Indicators of inequity in research and funding for sickle cell disease, cystic fibrosis and haemophilia: a descriptive comparative study
ArticlesOnline firstOpen access aDepartment of Epidemiology & Biostatistics, School of Public Health, Imperial College London, London, UK bDepartment of Primary Care & Public Health, School of Public Health, Imperial College London, London, UK cPrincess Royal University Hospital, King's College Hospital NHS Foundation Trust, London, UK dEthnicity and Health Unit, NIHR Applied Research Collaboration Northwest London, London, UK eFlorence Nightingale Faculty of Nursing, Midwifery & Palliative...
Indicators of inequity in research and funding for sickle cell disease, cystic fibrosis and haemophilia: a descriptive comparative study
Introduction Sickle cell disease is the fastest growing and one of the most common genetic disorders in the UK.1 Because of recurring severe pain crises and multi-systems organ damage resulting from the vaso-occlusion of blood vessels, it is a life-threatening and seriously debilitating condition and primarily affects people of Black African or Caribbean heritage.
Hydroxyurea for Children with Sickle Cell Disease in sub‐Saharan Africa: A Summary of the Evidence, Opportunities, and Challenges
REVIEW This article has been accepted for publication and undergone full peer review but has not been through the copyediting, typesetting, pagination and proofreading process, which may lead to differences between this version and the Version of Record. Please cite this article as doi:10.1002/phar.2792. Abstract Sickle cell disease (SCD) is a common and life-threatening inherited blood disorder that affects more than 300,000 newborns per year.
Peripheral blood features of iron overload in post‐splenectomy, type I congenital dyserythropoietic anemia
MORPHOLOGY UPDATE Daniel Dexter, Department of Paediatric Haematology, St Mary's Hospital, London, UK Search for more papers by this author D. Mark Layton, Centre for Haematology, St Mary's Hospital Campus of Imperial College Faculty of Medicine, St Mary's Hospital, London, UK Search for more papers by this author Kripesh Kiritkumar, Blood Sciences, St Mary's Hospital, London, UK Search for more papers by this author Barbara J.
Mitigating the effect of the COVID-19 pandemic on sickle cell disease services in African countries
An estimated 5% of the world's population are carriers for trait genes for haemoglobin disorders, mainly sickle cell disease. Over 75% of the global burden of sickle cell anaemia occurs in sub-Saharan Africa, and sickle cell disease is the most prevalent inherited genetic disease with 10–45% of the population carrying the sickle cell gene.
Show More
loading
Actions
Is this you?
As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.Get in touch with Daniel
Contact Daniel, search articles and posts on X, monitor coverage, and track replies from one place.
Learn more about Muck Rack